Home > Healthcare > Medical Devices > Therapeutic Devices > Carboxy Therapy Market

Carboxy Therapy Market Size - By Product Type (Table Top, Portable), By Application (Aesthetic Medicine, Gynecology, Angiology, Orthopaedics and Rheumatology, Sports Medicine), By End-use (Hospitals, Aesthetic Clinics, MedSpa) – Global Forecast 2023-2032

  • Report ID: GMI6463
  • Published Date: Aug 2023
  • Report Format: PDF

Carboxy Therapy Market Size

Carboxy Therapy Market size was valued at USD 98.4 million in 2022 and is estimated to account for USD 310.5 million by 2032. Carboxy therapy is a non-surgical cosmetic and medical treatment wherein medical-grade carbon dioxide gas is injected into the skin surface.
 

Carboxy Therapy Market

The injected carbon dioxide gas promotes increased blood circulation, collagen production, and tissue oxygenation in the treated area. It is used for cosmetic purposes, such as reducing cellulite, stretch marks, and dark circles, while also showing potential medical applications for conditions such as peripheral vascular diseases and diabetic foot ulcers. Carboxy therapy has been experiencing steady growth over the past few years due to its non-invasive nature and a wide range of applications. The rising demand for non-surgical cosmetic procedures, coupled with increasing awareness about the benefits of carboxy therapy is anticipated to augment market expansion.
 

The increasing awareness about benefits of carboxy therapy and the availability of portable devices have made the procedure more accessible to both practitioners and patients. For instance, DTA Medical has introduced the Carbo2 HP, an innovative trolley-mounted carboxytherapy unit that offers easy-tech instruments for precise micro-injection of medicinal carbon dioxide (CO2) under the skin (subcutaneously) or within the dermis (intra-dermally). Furthermore, the unit features specialized software capable of handling standard and personalized treatment programs. This technology ensures optimal safety and effectiveness during carboxytherapy procedures. Thus, portable devices allow for more flexibility in treatment settings, making carboxy therapy feasible in various clinical and non-clinical settings.
 

As the global population ages, the demand for anti-aging treatments has surged. Carboxy therapy, with its ability to stimulate collagen production and improve skin texture, has become a popular choice for individuals seeking to reduce the signs of aging, such as wrinkles, fine lines, and sagging skin. Thus, as the industry continues to evolve, further advancements and innovations are likely to enhance the efficacy and popularity of carboxy therapy as a sought-after cosmetic and medical treatment option, thereby estimated to accelerate market progress.
 

COVID-19 Impact

The COVID-19 pandemic had a negative impact on the carboxy therapy market, particularly during its initial stages. As countries implemented lockdowns and restrictions to control the spread of the virus, many non-essential medical procedures, including cosmetic treatments as carboxy therapy, were postponed, or cancelled. The fear of the COVID-19 and economic uncertainties further led to a decrease in consumer spending on non-essential treatments. However, as restrictions eased and safety measures were implemented, the market began to recover.
 

Additionally, there was a steady growth in the market, driven by increasing demand for non-invasive cosmetic procedures and growing awareness regarding therapy's benefits. While the pandemic posed challenges, the market's resilience and consumer confidence in elective procedures contributed to its gradual recovery.
 

Carboxy Therapy Market Trends

Increasing technological advancements in carboxy therapy technology have contributed to its rising popularity. For instance, in 2020, Cosmopro introduced DIOX, an innovative and advanced carboxytherapy system. The DIOX system was expertly designed and developed by specialist engineers, incorporating novel features for safety and ergonomic operation. It complies with medical and conformity standards, empowering practitioners to have complete control over the flow of sterile medical CO2 gas while facilitating monitoring throughout the procedure. These innovations have led to more efficient and effective delivery of carbon dioxide gas, ensuring better results and higher patient satisfaction. Thus, improved devices and techniques have made the procedure safer and more comfortable.
 

Furthermore, patients increasingly seek non-surgical alternatives to traditional cosmetic treatments, primarily driven by the desire for minimal downtime and less invasiveness of the procedures. For instance, in January 2023, the International Society of Aesthetic Plastic Surgery (ISAPS) unveiled the findings of its yearly global survey on aesthetic/cosmetic procedures, which revealed a 19.3% overall rise in procedures conducted by plastic surgeons in 2021. Additionally, the survey findings indicated that globally, there were over 17.5 million non-surgical procedures and 12.8 million surgical procedures performed.
 

Carboxy Therapy Market Analysis

Carboxy Therapy Market Size, By Product Type, 2021 - 2032 (USD Million)

The carboxy therapy market by product type is categorized table top and portable. The table top segment garnered USD 53.8 million revenue size in the year 2022. This dominance is driven by several key factors, including the convenience and portability of tabletop devices, which makes them easy to set up in various treatment settings. Their user-friendly interface enhances operational efficiency, and their space-efficient design is ideal for clinics with limited space.
 

Moreover, tabletop devices are cost-effective, making them accessible to a wider range of practitioners. Their flexibility allows for precise and effective carboxy therapy treatments, catering to diverse patient needs. Furthermore, the rising demand for non-invasive procedures aligns with the popularity of table top devices. Thus, the convenience, effectiveness, and alignment with market preferences contribute to the segment's dominance in the market.
 

Carboxy Therapy Market Share, By Application, 2022

The carboxy therapy market by application is categorized into aesthetic medicine, gynecology, angiology, orthopaedics and rheumatology, sports medicine, and others. The aesthetic medicine segment garnered USD 28.9 million revenue size in the year 2022. This dominance is fuelled by several key factors. Carboxy therapy's versatile cosmetic applications, addressing concerns such as cellulite, stretch marks, and dark circles attracts a large number of patients seeking non-surgical alternatives. Growing awareness and acceptance among patients and healthcare professionals, coupled with high patient satisfaction rate, contributes to its popularity.
 

Moreover, the treatment's minimal side effects, technological advancements, and alignment with the rising demand for non-invasive cosmetic procedures further reinforce its dominance in the aesthetic medicine market. Therefore, carboxy therapy maintains a prominent position as a preferred option for aesthetic enhancements.
 

Based on end-use, the carboxy therapy market is segmented into hospitals, aesthetic clinics, and medspa. The aesthetic clinics segment dominated the market and accounted for over 43% business share in the year 2022 and is anticipated to witness highest growth during the forecast period. Aesthetic clinics specialize in providing cosmetic and aesthetic treatments, making them ideal for offering carboxy therapy services. Their focus on non-surgical solutions aligns with the growing demand for minimally invasive procedures.
 

Furthermore, carboxy therapy's versatility in addressing various cosmetic issues complements the comprehensive range of treatments offered by these clinics, enhancing patient convenience and satisfaction. Moreover, with trained professionals and a reputation for safety and efficacy, aesthetic clinics attract a high patient volume and benefit from word-of-mouth referrals. Effective marketing and strategic geographic accessibility further reinforce their leading position in the market, making them preferred destinations for aesthetic enhancements.
 

U.S. Carboxy Therapy Market Size, 2020 -2032 (USD Million)

U.S. carboxy therapy market accounted for USD 36.4 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline. Advanced healthcare infrastructure ensuring widespread accessibility to carboxy therapy services, which aligns with the high demand for aesthetic treatments due to its reputation as a safe and effective option for cosmetic concerns across the U.S. is estimated to accelerate market growth. In addition, technological advancements lead to frequent introduction of sophisticated devices and techniques, leading to improved treatment outcomes. The U.S. witnessed a growing aging population base that drives the demand for anti-aging and skin rejuvenation treatments, making carboxy therapy a sought-after choice.
 

Furthermore, according to the International Society of Aesthetic Plastic Surgery (ISAPS), the U.S. took the lead as the top-performing country worldwide, accounting for 24.1% of all aesthetic procedures, including 30.4% of non-surgical procedures and 15.5% of surgical procedures. Therefore, the country's higher disposable income enables investments in elective cosmetic procedures, and the presence of numerous aesthetic clinics attracts patients seeking enhancements. Additionally, a favourable regulatory environment fosters trust and encourages the adoption of carboxy therapy. Consequently, the U.S.'s dominance significantly propels the growth of the market in the region.
 

Carboxy Therapy Market Share

Some of the eminent market participants operating in the carboxy therapy market include:

  • DTA Medical
  • Cosmopro
  • Carbossiterapia Italiana
  • Mezopharma
  • MBE Medical Divisions
  • Beijing Jontelaser Technologies Co., Ltd.
  • Alvi Prague
  • Kastner-Praxisbedarf
  • MEDAiON Plasma
  • Easymedical Group
  • Innoaesthetics. 

These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, new product development and launches to strengthen their product portfolio as well as gain a competitive edge over others.
 

Carboxy Therapy Industry News:

  • In January 2020, Cosmopro introduced DIOX, an innovative and advanced carboxy therapy system. The DIOX system was expertly designed and developed by specialist engineers, incorporating cutting-edge features for safety and ergonomic operation. It complies with medical and conformity standards, empowering practitioners to have complete control over the flow of sterile medical CO2 gas while facilitating monitoring throughout the procedure. Thus, such innovations have led to more efficient and effective delivery of carbon dioxide gas, ensuring better results and higher patient satisfaction.
     

Carboxy therapy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report


By Product Type (USD Million & Units)

  • Table top
  • Portable

By Application (USD Million)

  • Aesthetic medicine 
  • Gynecology
  • Angiology
  • Orthopaedics and rheumatology
  • Sports medicine
  • Others

By End-use (USD Million)

  • Hospitals
  • Aesthetic clinics
  • MedSpa

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Switzerland
    • The Netherlands
    • Denmark
    • Poland
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • New Zealand
    • Thailand
    • Vietnam
    • Indonesia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Turkey

 

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

The global market for carboxy therapy was valued at USD 98.4 million in 2022 and is estimated to account for USD 310.5 million by 2032, owing to the rising demand for non-surgical cosmetic procedures.

The aesthetic medicine segment garnered USD 28.9 million revenue size in the year 2022, backed by the carboxy therapy's versatile cosmetic applications, addressing concerns such as cellulite, stretch marks, and dark circles that attracts a large number of patients seeking non-surgical alternatives.

U.S. carboxy therapy market accounted for USD 36.4 million in 2022 and is predicted to witness substantial growth through 2032. Advanced healthcare infrastructure ensuring widespread accessibility to safe & effective carboxy therapy services for aesthetic treatments will accelerate market growth.

DTA Medical, Cosmopro, Carbossiterapia Italiana, Mezopharma, MBE Medical Divisions, Beijing Jontelaser Technologies Co., Ltd., Alvi Prague, Kastner-Praxisbedarf, MEDAiON Plasma, Easymedical Group, and Innoaesthetics.

Carboxy Therapy Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 345
  • Countries covered: 21
  • Pages: 227
 Download Free Sample